Granahan Investment Management’s Esperion Therapeutics ESPR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-293,766
| Closed | -$3.54M | – | 190 |
|
|
2021
Q3 | $3.54M | Sell |
293,766
-39,319
| -12% | -$474K | 0.07% | 169 |
|
|
2021
Q2 | $7.05M | Buy |
333,085
+17,165
| +5% | +$363K | 0.13% | 139 |
|
|
2021
Q1 | $8.86M | Sell |
315,920
-134,478
| -30% | -$3.77M | 0.19% | 101 |
|
|
2020
Q4 | $11.7M | Sell |
450,398
-37,701
| -8% | -$980K | 0.26% | 80 |
|
|
2020
Q3 | $18.1M | Buy |
488,099
+176,323
| +57% | +$6.55M | 0.62% | 50 |
|
|
2020
Q2 | $16M | Buy |
311,776
+81,322
| +35% | +$4.17M | 0.58% | 52 |
|
|
2020
Q1 | $7.27M | Sell |
230,454
-54,873
| -19% | -$1.73M | 0.39% | 68 |
|
|
2019
Q4 | $17M | Buy |
285,327
+130,699
| +85% | +$7.79M | 0.78% | 35 |
|
|
2019
Q3 | $5.67M | Buy |
+154,628
| New | +$5.67M | 0.31% | 78 |
|
|
2019
Q1 | – | Sell |
-108,200
| Closed | -$4.98M | – | 191 |
|
|
2018
Q4 | $4.98M | Sell |
108,200
-3,250
| -3% | -$149K | 0.35% | 81 |
|
|
2018
Q3 | $4.95M | Buy |
111,450
+4,100
| +4% | +$182K | 0.27% | 101 |
|
|
2018
Q2 | $4.21M | Buy |
+107,350
| New | +$4.21M | 0.25% | 111 |
|
|
2017
Q1 | – | Sell |
-248,030
| Closed | -$3.11M | – | 216 |
|
|
2016
Q4 | $3.11M | Hold |
248,030
| – | – | 0.11% | 163 |
|
|
2016
Q3 | $3.44M | Hold |
248,030
| – | – | 0.11% | 166 |
|
|
2016
Q2 | $2.45M | Buy |
248,030
+400
| +0.2% | +$3.95K | 0.09% | 184 |
|
|
2016
Q1 | $4.19M | Hold |
247,630
| – | – | 0.15% | 167 |
|
|
2015
Q4 | $5.51M | Sell |
247,630
-51,950
| -17% | -$1.16M | 0.19% | 154 |
|
|
2015
Q3 | $7.07M | Buy |
299,580
+30,000
| +11% | +$708K | 0.22% | 148 |
|
|
2015
Q2 | $22M | Buy |
269,580
+36,800
| +16% | +$3.01M | 0.62% | 58 |
|
|
2015
Q1 | $21.6M | Buy |
+232,780
| New | +$21.6M | 0.62% | 59 |
|